CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides. 2023 to 2027

CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere.

Will this disruptive technology change the world of In Vitro Diagnostics? What is the impact on Clinical Laboratories? How will social norms be affected?

The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size looking out 5 years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research Seminar - Burke Institute
Finance for Senior Executives - Harvard Business School

1. Market Guides

1.1. Strategic Situation Analysis
1.2. Guide for Executives, Marketing, Sales and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

2.1. Methodology
- 2.1.1. Methodology
- 2.1.2. Sources
- 2.1.3. Authors
2.2. CRISPR Gene Detection Definition In This Report
- 2.2.1. Research
- 2.2.2. Clinical Laboratory
- 2.2.3. Consumer Diagnostics
- 2.2.4. Public Service
- 2.2.5. Other
2.3. CRISPR
- 2.3.1. What is CRISPR?
- 2.3.2. What is Gene Detection?
- 2.3.3. The CRISPR Family
- 2.3.4. Sensitivity of CRISPR
2.4. Chromosomes, Genes and Epigenetics
- 2.4.1. Chromosomes
- 2.4.2. Genes
- 2.4.3. Epigenetics
2.5. Market Definition
- 2.5.1. Revenue Market Size
2.6. Perspective: Healthcare and the IVD Industry
- 2.6.1. Global Healthcare Spending
- 2.6.2. Spending on Diagnostics
- 2.6.3. Important Role of Insurance for Diagnostics

3. Market Overview

3.1. Players in a Dynamic Market
- 3.1.1. Academic Research Lab
- 3.1.2. Diagnostic Test Developer
- 3.1.3. Instrumentation Supplier
- 3.1.4. Chemical/Reagent Supplier
- 3.1.5. Pathology Supplier
- 3.1.6. Independent Clinical Laboratory
- 3.1.7. Public National/regional Laboratory
- 3.1.8. Hospital Laboratory
- 3.1.9. Physicians Office Lab (POLS)
- 3.1.10. Audit Body
- 3.1.11. Certification Body
3.2. Genetic Material Detection Markets, Examples and Discussion
- 3.2.1. Research Markets
- 3.2.2. Clinical Laboratories - Accuracy, Cost and Speed
  - 3.2.2.1. Multiplexing in the Lab and at the Point of Care
- 3.2.3. Consumer Diagnostics
  - 3.2.3.1. The CRISPR Consumer
  - 3.2.3.2. Why Consumers Like Multiplexing
- 3.2.4. Public Service Markets
  - 3.2.4.1. Public Health
  - 3.2.4.2. Public Security
  - 3.2.4.3. Environmental Monitoring
- 3.2.5. AgriBio and Other Markets
  - 3.2.5.1. AgriBio

4. Market Trends

4.1. Factors Driving Growth
- 4.1.1. Cost, Accuracy and Speed
- 4.1.2. The Economies of Multiplexing with Nucleic Acids
- 4.1.3. The New Agriculture
- 4.1.4. Pandemics and Pathogens
- 4.1.5. Health and Self - A Sea Change in Healthcare
4.2. Factors Limiting Growth
- 4.2.1. Ubiquitous PCR
- 4.2.2. The Shrinking Cost of All Things Genetic
- 4.2.3. Wellness has a downside
- 4.2.4. The Limits of Detection

5. CRISPR Recent Developments

5.1. Recent Developments - Importance and How to Use This Section
- 5.1.1. Importance of These Developments
- 5.1.2. How to Use This Section
5.2. CrisprBits Collaborates With MolBio Diagnostics
5.3. Sherlock Bioscience to Launch Free AI-Based Operating System
5.4. Sherlock Biosciences to Acquire Sense Biodetection
5.5. CRISPR Enzyme Discovery Opens Diagnostic Applications
5.6. Sherlock Biosciences Adds Ambient Amplification to Diagnostic Toolkit
5.7. Rice University Adapts CRISPR Enzyme to Create Ultra-Sensitive Test
5.8. CRISPR-Based Tb Test Shows High Sensitivity
5.9. Princeton Group Develops Cas13 Assay for Point-of-Care Use
5.10. Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
5.11. Sherlock Biosciences Raises $80M
5.12. Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
5.13. Medix Biochemica Acquires MyPols Biotec
5.14. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA
5.15. UCSD Developing At-Home Covid Test Leveraging CRISPR
5.16. Genome Diagnostics Makes €1M Investment in CRISPR Dx Startup Scope Biosciences
5.17. CRISPR SARS-CoV-2 Test Could be used for Asymptomatic Screening
5.18. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
5.19. Pandemic Accelerates Development of CRISPR Diagnostics
5.20. COVID Assays Use CRISPR and Smartphones
5.21. ERS Genomics Licenses CRISPR Patents to Vivlion
5.22. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test
5.23. ERS Genomics, FASMAC to Commercialize CRISPR-Cas9
5.24. The Nobel Prize in Chemistry 2020 - CRISPR Wins
5.25. Caspr Biotech Developing COVID Dx

6. Key Companies

6.1. 10x Genomics, Inc.
6.2. Agilent/Dako
6.3. Axxam
6.4. Beckman Coulter Diagnostics
6.5. Becton, Dickinson and Company
6.6. Binx Health
6.7. bioMérieux Diagnostics
6.8. Bio-Rad Laboratories, Inc.
6.9. Caspr Biotech
6.10. ERS Genomics
6.11. Illumina
6.12. Janssen Diagnostics
6.13. Locus Biosciences
6.14. Mammoth Biosciences
6.15. Myllia Biotechnology
6.16. Proof Diagnostics
6.17. Roche Molecular Diagnostics
6.18. Sherlock Biosciences
6.19. Thermo Fisher Scientific Inc.
6.20. Vivlion

7. The Global Market for CRISPR Gene Detection and Diagnostics

7.1. Global Market Overview by Country
- 7.1.1. Table - Global Market by Country
- 7.1.2. Chart-Global Market by Country
7.2. Global Market by Application-Overview
- 7.2.1. Table - Global Market by Application
- 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
- 7.2.3. Chart - Global Market by Application - Base Year
- 7.2.4. Chart - Global Market by Application - Final Year
- 7.2.5. Chart - Global Market by Application - Share by Year
- 7.2.6. Chart - Global Market by Application - Segment Growth
7.3. Global Market Organism-Overview
- 7.3.1. Table - Global Market by Organism
- 7.3.2. Chart - Global Market by Organism - Base/Final Year Comparison
- 7.3.3. Chart - Global Market by Organism - Base Year
- 7.3.4. Chart - Global Market by Organism - Final Year
- 7.3.5. Chart - Global Market by Organism - Share by Year
- 7.3.6. Chart - Global Market by Organism - Segment Growth

8. Global CRISPR Gene Detection and Diagnostics Markets - By Application

8.1. Research
- 8.1.1. Table Research - by Country
- 8.1.2. Chart-Research Growth
8.2. Clinical Laboratory
- 8.2.1. Table Clinical Laboratory - by Country
- 8.2.2. Chart-Clinical Laboratory Growth
8.3. Clinical Consumer
- 8.3.1. Table Clinical Consumer - by Country
- 8.3.2. Chart-Clinical Consumer Growth
8.4. Public Service
- 8.4.1. Table Public Service - by Country
- 8.4.2. Chart-Public Service Growth
8.5. Agriculture/Other
- 8.5.1. Table Agriculture/Other - by Country
- 8.5.2. Chart - Agriculture/Other Growth

9. Global CRISPR Gene Detection and Diagnostics Markets - by Organism

9.1. Human
- 9.1.1. Table Human - by Country
- 9.1.2. Chart-Human Growth
9.2. Pathogen
- 9.2.1. Table Pathogen - by Country
- 9.2.2. Chart-Pathogen Growth
9.3. Other Organism
- 9.3.1. Table Other Organism - by Country
- 9.3.2. Chart-Other Organism Growth

10. Appendices

10.1. United States Medicare System: laboratory Fees Schedule
10.2. The Most Used IVD Assays
10.3. The Highest Grossing Assays
10.4. The Whole Genome Sequence of SARS-CoV-2
10.5. Global Listing of Sequencing Establishments - Location & Contacts

Table of Tables

Table 1: The Base Pairs
Table 2: CRISPR Assays Types & Times
Table 3: CRISPR Assays Readouts & Application
Table 4: The Base Pairs
Table 5: Market Players by Type
Table 6: The Different Markets for Genetic Detection
Table 7: Other Uses for CRISPR Gene Detection
Table 8: The Factors Driving Growth
Table 9: Factors Limiting Growth
Table 10: Global Market by Region
Table 11: Global Market by Application
Table 12: Global Market by Organism
Table 13: Research by Country
Table 14: Clinical Laboratory by Country
Table 15: Clinical Consumer by Country
Table 16: Public Service by Country
Table 17: Agriculture/Other by Country
Table 18: Human by Country
Table 19: Pathogen by Country
Table 20: Other Organism by Country
Table 21: Clinical Lab Fee Schedule
Table 22: The Most Common Assays
Table 23: Largest Revenue Assays
Table 24: List of Global Sequencing Locations

Table of Figures

Figure 1: DNA Strands and Chromosomes
Figure 2: Karyogram of Human Chromosomes
Figure 3: Size of Various Genomes
Figure 4: Global Healthcare Spending
Figure 5: The Lab Test Pie
Figure 6: The Road to Diagnostics
Figure 7: Cost To Sequence a Human Genome
Figure 8: Base Year Country Market Share Chart
Figure 9: Global Market by Application-Base vs. Final Year
Figure 10: Global Market by Application Base Year
Figure 11: Global Market by Application Final Year
Figure 12: Application Type Share by Year
Figure 13: by Application Segment Growth
Figure 14: by Organism - Base vs. Final Year
Figure 15: by Organism Market Base Year
Figure 16: by Organism Market Final Year
Figure 17: by Organism Share by Year
Figure 18: by Organism Segment Growth
Figure 19: Research Growth
Figure 20: Clinical Laboratory Growth
Figure 21: Clinical Consumer Growth
Figure 22: Public Service Growth
Figure 23: Agriculture/Other Growth
Figure 24: Human Growth
Figure 25: Pathogen Growth
Figure 26: Other Organism Growth